High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$274M
$274,091,497
Total Sells (Filtered)
$1.1M
$1,056,722
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KOD
P
Kodiak Sciences Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary BuyΔOwn +16.2%
2025-12-18
$5,000,844Whale
|
||||||
| KOD |
Kodiak Sciences Inc.
|
Director
Discretionary BuyΔOwn +16.2%
|
2025-12-18 | $5,000,844Whale | P | Form 4 |
|
KOD
P
Kodiak Sciences Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary BuyΔOwn +15.0%
2025-12-18
$54,999,164MEGA
|
||||||
| KOD |
Kodiak Sciences Inc.
|
Director
Discretionary BuyΔOwn +15.0%
|
2025-12-18 | $54,999,164MEGA | P | Form 4 |
|
KYMR
P
Kymera Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary BuyΔOwn +31.3%
2025-12-11
$14,378,512MEGA
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +31.3%
|
2025-12-11 | $14,378,512MEGA | P | Form 4 |
|
KYMR
P
Kymera Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary BuyΔOwn +30.1%
2025-12-11
$158,121,406MEGA
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +30.1%
|
2025-12-11 | $158,121,406MEGA | P | Form 4 |
|
DNLI
P
Denali Therapeutics Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary Buy
2025-12-11
$36,644,891MEGA
|
||||||
| DNLI |
Denali Therapeutics Inc.
|
Director
Discretionary Buy
|
2025-12-11 | $36,644,891MEGA | P | Form 4 |
|
DNLI
P
Denali Therapeutics Inc.
BAKER BROS. ADVISORS LP
• Director
Discretionary Buy
2025-12-11
$3,332,247Large
|
||||||
| DNLI |
Denali Therapeutics Inc.
|
Director
Discretionary Buy
|
2025-12-11 | $3,332,247Large | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-20
$10,760
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-20 | $10,760 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-20
$118,690
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-20 | $118,690 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-20
$121,395
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-20 | $121,395 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-20
$11,000
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-20 | $11,000 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-12
$56,602
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-12 | $56,602 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-12
$91,431
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-12 | $91,431 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-12
$8,273
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-12 | $8,273 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-12
$625,331
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-12 | $625,331 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-11
$232,812
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-11 | $232,812 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-11
$7,827
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-11 | $7,827 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-11
$86,481
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-11 | $86,481 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-11
$21,073
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-11 | $21,073 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-10
$21,290
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-10 | $21,290 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-10
$1,929
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-10 | $1,929 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-10
$182,973
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-10 | $182,973 | P | Form 4 |
|
TRDA
P
Entrada Therapeutics, Inc.
BAKER BROS. ADVISORS LP
• 10% Owner
Discretionary Buy
2025-11-10
$16,563
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Buy
|
2025-11-10 | $16,563 | P | Form 4 |
|
KALA
S
KALA BIO, Inc.
BAKER BROS. ADVISORS LP
• Other
Discretionary SellΔOwn -52.1%
2025-10-01
$640,654
|
||||||
| KALA |
KALA BIO, Inc.
|
Other
Discretionary SellΔOwn -52.1%
|
2025-10-01 | $640,654 | S | Form 4 |
|
KALA
S
KALA BIO, Inc.
BAKER BROS. ADVISORS LP
• Other
Discretionary SellΔOwn -52.1%
2025-10-01
$70,076
|
||||||
| KALA |
KALA BIO, Inc.
|
Other
Discretionary SellΔOwn -52.1%
|
2025-10-01 | $70,076 | S | Form 4 |
|
KALA
S
KALA BIO, Inc.
BAKER BROS. ADVISORS LP
• Other
Discretionary SellΔOwn -18.0%
2025-09-30
$34,114
|
||||||
| KALA |
KALA BIO, Inc.
|
Other
Discretionary SellΔOwn -18.0%
|
2025-09-30 | $34,114 | S | Form 4 |
|
KALA
S
KALA BIO, Inc.
BAKER BROS. ADVISORS LP
• Other
Discretionary SellΔOwn -18.0%
2025-09-30
$311,879
|
||||||
| KALA |
KALA BIO, Inc.
|
Other
Discretionary SellΔOwn -18.0%
|
2025-09-30 | $311,879 | S | Form 4 |